ConductScience.org, home

Trial · NCT07492563

Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay

NCT07492563, Not yet recruiting, LABORATORIOS INDUFAR

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay. Trials, record NCT07492563. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07492563

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay
NCT number
NCT07492563
Status
Not yet recruiting
Enrollment
300 participants, estimated
Lead sponsor
LABORATORIOS INDUFAR
Conditions
Obesity, Type 2 Diabetes Mellitus, Overweight With Comorbidities
Interventions
Tirzepatide (T.G.)
First posted
2026-03-25
Last updated
2026-03-25

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Adverse Events12 monthsFrequency, type, severity, causality, and outcome of adverse events Special focus on serious adverse events and events of special interest.
SecondaryChange in Body Weight12 monthsDescription: Mean change in body weight from baseline Unit of measure: Kilograms (kg)
SecondaryChange in body mass index (BMI)12 monthsDescription: Mean change in BMI calculated as weight(kg)/height(m)² Unit of measure: kg/m²
SecondaryChange in systolic and diastolic blood pressure12 monthsDescription: Mean change in systolic and diastolic blood pressure measured with calibrated digital sphygmomanometer Unit of measure: mmHg
SecondaryChange in total cholesterol, HDL cholesterol, tryglicerides12 monthsDescription: Mean change in serum total cholesterol levels using enzymatic method Unit of measure: mg/dL
SecondaryReasons for treatment discontinuation12 monthsDescription: Classification of reasons for treatment discontinuation (adverse events, lack of efficacy, patient decision, others) Unit of measure: Number and percentage by category

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07492563

GET https://conductscience.org/api/trials/v1/NCT07492563/registered